It is a e-commerce limited liability partnership based in Mumbai, Maharashtra, India, established in 2016.
2016 | Mumbai, Maharashtra, India | ActiveMed Xpress Pharma India Llp, a active limited liability partnership, was established on 08 March 2016 in Mumbai, Maharashtra, India. Engaging in online healthcare product retail within the e-commerce sector, it holds LLPIN: AAF-8773. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.12 M.
Its leadership includes Prafull Babu Kalyanshetti (Designated Partner), Mohammadhussain Abdulgani Rayma (Designated Partner), Nitin Kakasaheb Suryavanshi (Designated Partner). Past directors included Ankush Ramchandra Jadhav, Faiza Mumtahir Shaikh, Rahul Buvasaheb Bade. It holds ₹6.53 Cr open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2024. It is based at 30Th Floor, A Wing Unit No 3005-3006, Marathon Futurex,, Nm Joshi Marg, Mafatlal Mills Compound, Lower Parel,, Mumbai, Maharashtra, 400013.
AAF-8773
08 March 2016
₹0.12 M
Roc Mumbai
Active
Explore comprehensive insights into Med Xpress Pharma India Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prafull Babu Kalyanshetti | Designated Partner | 08 Mar 2016 | Current |
| Mohammadhussain Abdulgani Rayma | Designated Partner | 01 Apr 2025 | Current |
| Nitin Kakasaheb Suryavanshi | Designated Partner | 01 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Designated Partner | 01 Apr 2025 | Past |
| Pramod Abcsdd | Designated Partner | 01 Apr 2024 | Past |
| Pramod Abcsdd | Designated Partner | 01 Apr 2024 | Past |
| Pramod Abcsdd | Partner | 31 Mar 2025 | Past |
| Pramod Abcsdd | Partner | 31 Mar 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Med Xpress Pharma India Llp, for the financial year ended 2023, experienced modest growth in revenue, with a 2.09% increase. The company also saw a slight improvement in profitability, with a 3.48% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
Unlock access to Med Xpress Pharma India Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹65,340,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2025 | Saraswat Coop Bank Limited. | ₹3.05 M | Open |
| 14 Oct 2024 | Axis Bank Limited | ₹4.00 Cr | Open |
| 30 Nov 2023 | Saraswat Coop Bank Ltd | ₹2.29 M | Open |
| 25 Nov 2022 | Saraswat Coop Bank Ltd | ₹2.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Med Xpress Pharma India Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Med Xpress Pharma India Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Med Xpress Pharma India Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Mohammadhussain Abdulgani Rayma was appointed as a Designated Partner was appointed as a Designated Partner on 01 Apr 2025 & has been associated with this company since 8 months 6 days . was documented.
The activity Nitin Kakasaheb Suryavanshi was appointed as a Designated Partner was appointed as a Designated Partner on 01 Apr 2025 & has been associated with this company since 8 months 6 days . was completed.
Progress on Med Xpress Pharma India Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.
Progress on A charge with Saraswat Coop Bank Limited. amounted to Rs. 3.05 M with Charge ID 101106704 was registered on 28 Mar 2025. was documented.
The activity A charge with Axis Bank Limited of Rs. 40.00 M registered on 14 Oct 2024 with Charge ID 100985882 was modified on 30 Nov 2024. was completed.
The activity A charge with Axis Bank Limited amounted to Rs. 40.00 M with Charge ID 100985882 was registered on 14 Oct 2024. was completed.
The LLPIN of Med Xpress Pharma India Llp is AAF-8773.
Med Xpress Pharma India Llp is headquartered at 30Th Floor, A Wing Unit No 3005-3006, Marathon Futurex,, Nm Joshi Marg, Mafatlal Mills Compound, Lower Parel,, Mumbai, Maharashtra, 400013.
Med Xpress Pharma India Llp was incorporated on 08 March 2016.
The current directors of Med Xpress Pharma India Llp are
The primary industry of Med Xpress Pharma India Llp is E-Commerce.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX